• Cytarabine (AraC): Applied Workflows in Leukemia & Cell Deat

  2026-05-15

  Cytarabine (AraC) is a gold-standard apoptosis inducer in leukemia research, offering precision targeting of DNA synthesis and p53-mediated pathways. This article provides advanced, evidence-backed workflows, troubleshooting strategies, and contextualizes the latest viral-host cell death insights for next-generation experimental design.

• E-64d (SKU A1903): Reliable Cysteine Protease Inhibition in

  2026-05-15

  This article addresses key laboratory challenges in cell viability, apoptosis, and neuroprotection research, demonstrating how E-64d (SKU A1903) provides reproducible and evidence-backed solutions. Drawing on peer-reviewed data and real-world scenarios, it guides researchers in protocol optimization, data interpretation, and vendor selection for high-confidence cysteine protease inhibition.

• JHU-083: Applied Protocols for Glutaminase Pathway Research

  2026-05-14

  JHU-083, a potent 6-diazo-5-oxo-L-norleucine precursor, enables selective glutaminase inhibition in cerebral CD11b cells—empowering advanced workflows for neurological disease models and experimental cerebral malaria research. This guide delivers actionable protocols, troubleshooting insights, and data-backed innovation inspired by state-of-the-art oxidative stress research.

• Genistein in Translational Oncology: Mechanisms, Models, Mom

  2026-05-14

  This thought-leadership article dissects the mechanistic underpinnings and translational potential of Genistein (5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one) as a selective tyrosine kinase inhibitor in cancer research. Integrating new evidence on cytoskeleton-dependent autophagy and workflow strategies for apoptosis, proliferation, and chemoprevention, it provides protocol guidance, strategic insights, and a forward-looking perspective for translational researchers. The discussion is grounded in peer-reviewed findings, comparative product intelligence, and APExBIO’s rigorously validated Genistein (SKU A2198).

• Continuous Dopaminergic Delivery with Rotigotine in PD and R

  2026-05-13

  This review details the development and clinical impact of the rotigotine transdermal system, emphasizing its innovation in providing continuous dopamine receptor stimulation for Parkinson’s disease (PD) and restless legs syndrome (RLS). The article examines the pharmacological rationale, clinical trial evidence, and translational implications for researchers studying dopaminergic signaling and antiparkinsonian agents.

• Nose-to-Brain Rotigotine Nanoparticles for Parkinson’s Disea

  2026-05-13

  This study demonstrates the development and evaluation of rotigotine-loaded chitosan nanoparticles for intranasal delivery in cellular and animal models of Parkinson’s disease. The nanoparticle system enhances brain targeting, neuroprotection, and therapeutic efficacy, addressing limitations of conventional administration routes.

• Macrophage EV microRNA-660 Drives Breast Cancer Metastasis

  2026-05-12

  This study uncovers how tumor-associated macrophage (TAM)-derived extracellular vesicles (EVs) deliver microRNA-660 to breast cancer cells, suppressing KLHL21 and activating NF-κB signaling to promote metastasis. The findings highlight a novel intercellular communication axis with implications for targeted intervention in metastatic breast cancer.

• Gap26 Connexin 43 Mimetic Peptide: Mitochondrial Transfer In

  2026-05-12

  Explore how Gap26, a connexin 43 mimetic peptide, advances research into mitochondrial transfer and gap junction modulation. This article uniquely integrates mechanistic depth and assay guidance, setting it apart from previous overviews.

• Phenothiazines Enhance Macrophage Antibacterial Defense via

  2026-05-11

  This study demonstrates that phenothiazines, including perphenazine, potentiate macrophage antibacterial activity by simultaneously inducing reactive oxygen species and autophagy. These findings illuminate a host-directed therapy mechanism with translational implications for combating intracellular bacterial infections and circumventing antibiotic resistance.

• Nigericin Sodium Salt: Potassium Ionophore for Controlled Io

  2026-05-11

  Nigericin sodium salt enables controlled potassium/proton exchange across biological membranes, supporting workflows that require precise cytoplasmic pH modulation, ion transport studies, and platelet aggregation assays. It should not be used for diagnostic or medical applications and demands adherence to solubility and storage requirements for reproducibility.

• Spleen-Targeted mRNA Vaccine Drives TLS Formation in HCC

  2026-05-10

  Lin et al. introduce a spleen-targeted neoantigen mRNA vaccine (STNvac) that elicits robust ISG15+ CD8+ T cell responses and induces tertiary lymphoid structures (TLS) in hepatocellular carcinoma. This mechanistic advance informs the design of organ-targeted mRNA immunotherapies with improved antitumor efficacy.

• PA-824 (SKU A1736): Reliable Solutions for Tuberculosis Rese

  2026-05-09

  This scenario-driven article equips biomedical researchers and lab technicians with authoritative strategies to overcome common challenges in tuberculosis assays using PA-824 (SKU A1736). Drawing on validated protocols, peer-reviewed evidence, and direct comparison with alternative sources, it demonstrates how this high-purity bicyclic nitroimidazole derivative from APExBIO ensures reproducible, sensitive, and workflow-efficient results.

• Dissecting VEGFR-3: SAR131675 in Translational Fibrosis & Ca

  2026-05-09

  This thought-leadership article explores the mechanistic and translational value of SAR131675, a highly selective ATP-competitive VEGFR-3 inhibitor, in preclinical models of cancer and fibrosis. Integrating mechanistic insights from recent hepatic fibrosis research, it provides strategic guidance for translational researchers on optimizing anti-lymphangiogenic and anti-angiogenic workflows. The article advances the discussion beyond typical product pages by linking cross-disease applications, protocol parameters, and maturity caveats, while referencing key literature and workflow resources.

• Refining In Vitro Drug Response Assessment in Cancer Biology

  2026-05-08

  Schwartz's dissertation introduces a nuanced framework for distinguishing between proliferative arrest and cell death in vitro, clarifying two widely used drug response metrics. This approach improves preclinical evaluation by informing more precise experimental interpretation and translational decisions.

• Nerve-Dependent HDAC1 Regulation Governs Axolotl Limb Regene

  2026-05-07

  This study uncovers how nerve-mediated upregulation of HDAC1 is essential for successful blastema formation and limb regeneration in axolotls. By demonstrating that pharmacological inhibition of HDACs—specifically with MS-275—impairs regeneration, the work highlights a critical epigenetic axis linking neural signals to regenerative outcomes.

451 records 18/31 page Previous Next First page 上5页 1617181920 下5页 Last page